On a mission to defend more stroke patients from a life of disability, Stanford Medicine colleagues drive research that extends the window for effective intervention.
Stanford researchers have developed a synthetic, tumor-targeting molecule that promotes immune activation and tumor regression in mice.
A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies.
A potential COVID-19 vaccine, delivered via a squirt up the nose, shows promise in mice.
A Stanford Medicine bioengineer sets out to create a world fueled by synthetic biology.
Psychiatrist Lawrence Fung expanded his autism research into developing a program that helps those on the spectrum find jobs.
COVID-19 vaccinations may be given to children as young as 5. Stanford pediatricians answer frequently asked questions about the vaccine.
Knowing why women have tougher recoveries from brain injuries creates an opportunity to improve treatment for female patients.
